Skip to main content
Equibles

Decheng Capital LLC

Position in EQ — Equillium, Inc.

CIK 2010850 MENLO PARK, CA
Back to EQ Full portfolio

Position in EQ

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,231,385
+$5,336,769 QoQ
Shares Held
4,447,308
0.0% QoQ
Ownership
7.01%
of shares outstanding
% of Portfolio
1.94%
of 13F equity value
Holder Rank
#2
of 60 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EQ Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Decheng Capital LLC holds $731,749,065 across 14 Biotechnology names. EQ ranks #7 (1.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 6,371,669 $452,707,082
2 NUVB
Nuvation Bio Inc.
 25,954,439 $147,421,213
3 AARD
Aardvark Therapeutics, Inc.
 3,917,299 $22,563,642
4 ACRS
Aclaris Therapeutics, Inc.
 4,041,736 $21,380,783
5 UPB
Upstream Bio, Inc.
 2,724,868 $18,856,086
6 RCUS
Arcus Biosciences, Inc.
 464,779 $14,329,136
7 EQ
Equillium, Inc.
This page 		4,447,308 $14,231,385
8 RVMD
Revolution Medicines, Inc.
 52,667 $9,863,475

All Filings in EQ

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,231,385 4,447,308
2026-03-31 $8,894,616 4,447,308
2025-12-31 $6,893,327 4,447,308
2025-09-30 $6,359,650 4,447,308
2025-06-30 $1,423,138 4,447,308
2025-03-31 $1,734,450 4,447,308
2024-12-31 $3,335,481 4,447,308
2024-09-30 $3,691,265 4,447,308
2024-06-30 $3,068,642 4,447,308
2024-03-31 $10,273,281 4,447,308
2023-12-31 $3,202,061 4,447,308